Clinical Characteristics of Korean Patients with Lung Cancer Who Have Programmed Death-Ligand 1 Expression

BACKGROUND: Programmed death-ligand 1 (PD-L1), a transmembrane protein, binds to the programmed death-1 (PD-1) receptor, and anti-PD-1 therapy enables immune responses against tumors. This study aimed to assess clinical characteristics of PD-L1 expression using immunohistochemistry among Korean pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Ha-Young, Oh, In-Jae, Kho, Bo Gun, Kim, Tae-Ok, Shin, Hong-Joon, Park, Cheol Kyu, Kwon, Yong-Soo, Kim, Yu-Il, Lim, Sung-Chul, Kim, Young-Chul, Choi, Yoo-Duk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Tuberculosis and Respiratory Diseases 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6609527/
https://www.ncbi.nlm.nih.gov/pubmed/30841018
http://dx.doi.org/10.4046/trd.2018.0070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6609527/
https://www.ncbi.nlm.nih.gov/pubmed/30841018
http://dx.doi.org/10.4046/trd.2018.0070

Ejemplares similares